Extracted from this filing and checked against the source text.
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
BNB PLUS CORP. completed an acquisition involving Spindle Biotech Inc. for cash of $625,000 and 750,000 restricted shares of common stock, plus potential earn-out (closed 2023-07-12).
- Action
- acquisition
- Counterparty
- Spindle Biotech Inc.
- Consideration
- cash of $625,000 and 750,000 restricted shares of common stock, plus potential earn-out
- Closing
- 2023-07-12
Exact text from the filing
the transactions contemplated by the Purchase Agreement, the Purchaser agreed to pay or issue to the Sellers, as applicable, on a pro rata basis: (i) a cash purchase price of $625,000, as adjusted for debt of Spindle as of the closing date and expenses related to the transaction, which was paid to the Sellers on the Closing Date; (ii) 750,000 restricted shares
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
BNB PLUS CORP. entered into Share Purchase Agreement with Spindle Biotech Inc., the Sellers, and Lai Him Chung valued at $625,000 (effective 2023-07-12).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- Spindle Biotech Inc., the Sellers, and Lai Him Chung
- Value
- $625,000
- Effective
- 2023-07-12
Exact text from the filing
On July 12, 2023 (the “Closing Date”), Spindle Acquisition Corp., a corporation existing under the laws of the Province of Ontario (the “Purchaser”), and a wholly-owned subsidiary of Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), entered into a Share Purchase Agreement (the “Purchase Agreement”) with Spindle Biotech Inc., a corporation existing under the federal laws of Canada (“Spindle”), the persons listed on Schedule 1.1 of the Purchase Agreement (the “Sellers”) and Lai Him Chung, as Seller Representative.
View on SEC.gov